Israel Englander Intercept Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $835,139 - $1.76 Million	-91,073 Reduced 13.35%	591,333 $6.54 Million
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $3.69 Million - $6.39 Million	-294,300 Reduced 30.13%	682,406 $9.17 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $2.33 Million - $3.24 Million	-201,043 Reduced 17.07%	976,706 $12.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $10.3 Million - $16.6 Million	845,142 Added 254.1%	1,177,749 $16.4 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $1.75 Million - $3.05 Million	-155,659 Reduced 31.88%	332,607 $4.59 Million
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $954,778 - $1.27 Million	-71,412 Reduced 12.76%	488,266 $7.94 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $7.99 Million - $10.9 Million	559,678 New	559,678 $9.12 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $337,064 - $531,155	-25,948 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $48,157 - $76,317	3,115 Added 13.64%	25,948 $518,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $1.51 Million - $2.94 Million	-77,875 Reduced 77.33%	22,833 $527,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $2.47 Million - $4.28 Million	100,708 New	100,708 $2.49 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $6.62 Million - $13 Million	-141,662 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $4.04 Million - $9.91 Million	83,490 Added 143.52%	141,662 $8.92 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $3.34 Million - $7.22 Million	58,172 New	58,172 $7.21 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $350,144 - $480,024	-5,966 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$77.77 - $120.68 $8.53 Million - $13.2 Million	-109,675 Reduced 94.84%	5,966 $475,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $7.88 Million - $12.2 Million	101,334 Added 708.28%	115,641 $3.82 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $935,564 - $1.23 Million	10,188 Added 247.34%	14,307 $1.6 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $547,511 - $807,067	-6,382 Reduced 60.78%	4,119 $415,000
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $5.84 Million - $8.42 Million	-66,008 Reduced 86.27%	10,501 $1.33 Million
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $9.52 Million - $13.6 Million	-158,671 Reduced 67.47%	76,509 $6.42 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $7.79 Million - $9.93 Million	147,719 Added 168.9%	235,180 $14.5 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $79,035 - $98,808	-1,358 Reduced 1.53%	87,461 $5.11 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $5.06 Million - $10.5 Million	88,819	88,819 $5.16 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account